06425006 · Active · incorporated 18 years, 9 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
Crescendo Biologics develops novel T cell enhancing therapeutics for immuno-oncology, focusing on Humabody® VH therapeutics.
https://www.crescendobiologics.com/
Crescendo Biologics Limited is a private limited company registered at Companies House under number 06425006, incorporated on 13 November 2007, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 215 filings for this company, including 7 funding rounds. Its most recent round closed in July 2022, raising £22.5m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 7 | Jul 2022 | £22.5m | £0.96 |
| Round 6 | Jul 2021 | £18.2m | £0.44 |
| Round 5 | Apr 2018 | £31.2m | £0.55 |
| Round 4 | Sep 2015 | £2.3m | £1.32 |
| Round 3 | Feb 2015 | £7.5m | £0.01 |
| Round 2 | Jul 2014 | £1m | £1.10 |
Showing the 6 most recent of 7 rounds.
Showing the 11 most recent of 215 filings.
See the complete cap table with every shareholder, founder tags, dilution across 58 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.